Sales of Merck's blockbuster cancer immunotherapy drug Keytruda rose 10% to $8.14 billion, and sales of its hypertension drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback